| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Apr 18, 2016 | Option Exercise | $1.05 | 36,000 | 37,746 | 31,674 | Apr 20, 2016, 05:49 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Apr 18, 2016 | Sale | $18.50 | 36,000 | 666,000 | 8,340 | Apr 20, 2016, 05:49 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Mar 04, 2016 | Option Exercise | $13.66 | 7,500 | 102,450 | 8,340 | Mar 08, 2016, 05:57 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Jun 05, 2015 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | Jun 09, 2015, 05:54 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Jun 05, 2015 | Sale | $18.95 | 2,000 | 37,900 | 840 | Jun 09, 2015, 05:54 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | May 05, 2015 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | May 07, 2015, 04:52 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | May 05, 2015 | Sale | $17.62 | 2,000 | 35,240 | 840 | May 07, 2015, 04:52 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Apr 06, 2015 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | Apr 07, 2015, 04:30 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Apr 06, 2015 | Sale | $17.44 | 2,000 | 34,880 | 840 | Apr 07, 2015, 04:30 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Mar 05, 2015 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | Mar 09, 2015, 05:58 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Mar 05, 2015 | Sale | $17.15 | 2,000 | 34,300 | 840 | Mar 09, 2015, 05:58 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Feb 05, 2015 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | Feb 06, 2015, 05:36 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Feb 05, 2015 | Sale | $16.87 | 2,000 | 33,740 | 840 | Feb 06, 2015, 05:36 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Jan 05, 2015 | Sale | $17.59 | 2,000 | 35,180 | 840 | Jan 07, 2015, 06:39 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Jan 05, 2015 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | Jan 07, 2015, 06:39 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Dec 05, 2014 | Option Exercise | $1.75 | 2,000 | 3,510 | 2,840 | Dec 09, 2014, 05:48 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Dec 05, 2014 | Sale | $14.01 | 2,000 | 28,028 | 840 | Dec 09, 2014, 05:48 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Dec 01, 2014 | Option Exercise | $1.75 | 20,000 | 35,100 | 20,840 | Dec 03, 2014, 08:00 PM | |
| ADMS | Adamas Pharmaceuticals Inc | McClure Natalie | SVP, Product Development | Dec 01, 2014 | Sale | $14.50 | 20,000 | 290,000 | 840 | Dec 03, 2014, 08:00 PM |
Menu